Skip to main content
. 2020 Aug 5;128(2):234–247. doi: 10.1016/j.ophtha.2020.07.060

Table 3.

Reported Rates of Nonpersistence to Treatment or Monitoring Visits over Time (Excluding Patient Death or Transfer of Care)

Months Proportion of Patient Nonpersistent with Treatment at Each Time Point
N, %
Curtin (n=284 380) Lad (n=459 237) Range (%)
Boluanger (n = 201) Droege (n = 95) Kruger Falk (n = 855) Rasmussen 2013 (n = 555) Rasmussen 2017 (n = 1027) Subhi (n = 116) Heimes (n = 191) Holz (n = 2227) Westborg (n = 932) Ehlken 2018 (n=362)
6 174 094 (44.7)
12 37 (3.6) 16 (13.8) 532 (23.9) 503 (50.8) 68 (18.8) 104 165 (53.6) 213 645 (57.4) 3.6–57.4
18 112 647 (61.7) 234 239 (65.6) 61.7 – 65.6
24 10 (7.0) 16 (13.8) 60 (31.4) 1043 (46.8) 244 743 (71.0) 7.0–71.0
36
48 36 (4.2)
60 63 (31.3) 60 (10.8) 10.8–31.3